579 related articles for article (PubMed ID: 10792371)
21. [Interleukin-8 is an important inflammatory mediator in hemorrhagic rectocolitis and Crohn disease].
Reimund JM; Duclos B; Dumont S; Muller C; Baumann R; Poindron P
Gastroenterol Clin Biol; 1997; 21(2):131-7. PubMed ID: 9161479
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase-3 production by gut IgG plasma cells in chronic inflammatory bowel disease.
Gordon JN; Pickard KM; Di Sabatino A; Prothero JD; Pender SL; Goggin PM; MacDonald TT
Inflamm Bowel Dis; 2008 Feb; 14(2):195-203. PubMed ID: 18022869
[TBL] [Abstract][Full Text] [Related]
23. Epithelial expression of interleukin-37b in inflammatory bowel disease.
Imaeda H; Takahashi K; Fujimoto T; Kasumi E; Ban H; Bamba S; Sonoda H; Shimizu T; Fujiyama Y; Andoh A
Clin Exp Immunol; 2013 Jun; 172(3):410-6. PubMed ID: 23600829
[TBL] [Abstract][Full Text] [Related]
24. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
[TBL] [Abstract][Full Text] [Related]
25. Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
Li J; Liu L; Zhao Q; Chen M
Dig Dis Sci; 2020 Jul; 65(7):1971-1979. PubMed ID: 31808003
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
[TBL] [Abstract][Full Text] [Related]
27. Modulation of cytokine release from colonic explants by bacterial antigens in inflammatory bowel disease.
Dionne S; Laberge S; Deslandres C; Seidman EG
Clin Exp Immunol; 2003 Jul; 133(1):108-14. PubMed ID: 12823284
[TBL] [Abstract][Full Text] [Related]
28. Quantitive cytokine mRNA expression profiles in the colonic mucosa of patients with steroid naïve ulcerative colitis during active and quiescent disease.
Matsuda R; Koide T; Tokoro C; Yamamoto T; Godai T; Morohashi T; Fujita Y; Takahashi D; Kawana I; Suzuki S; Umemura S
Inflamm Bowel Dis; 2009 Mar; 15(3):328-34. PubMed ID: 18942752
[TBL] [Abstract][Full Text] [Related]
29. Lamina propria and circulating interleukin-8 in newly and previously diagnosed pediatric inflammatory bowel disease patients.
Reddy KP; Markowitz JE; Ruchelli ED; Baldassano RN; Brown KA
Dig Dis Sci; 2007 Feb; 52(2):365-72. PubMed ID: 17219072
[TBL] [Abstract][Full Text] [Related]
30. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
McKaig BC; McWilliams D; Watson SA; Mahida YR
Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
[TBL] [Abstract][Full Text] [Related]
31. Antioxidants inhibit the in vitro production of inflammatory cytokines in Crohn's disease and ulcerative colitis.
Reimund JM; Allison AC; Muller CD; Dumont S; Kenney JS; Baumann R; Duclos B; Poindron P
Eur J Clin Invest; 1998 Feb; 28(2):145-50. PubMed ID: 9541129
[TBL] [Abstract][Full Text] [Related]
32.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
33. Elevated cell-associated levels of interleukin 1beta and interleukin 6 in inflamed mucosa of inflammatory bowel disease.
Grottrup-Wolfers E; Moeller J; Karbach U; Muller-Lissner S; Endres S
Eur J Clin Invest; 1996 Feb; 26(2):115-22. PubMed ID: 8904520
[TBL] [Abstract][Full Text] [Related]
34. Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.
Andus T; Daig R; Vogl D; Aschenbrenner E; Lock G; Hollerbach S; Köllinger M; Schölmerich J; Gross V
Gut; 1997 Nov; 41(5):651-7. PubMed ID: 9414973
[TBL] [Abstract][Full Text] [Related]
35. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome.
Raddatz D; Bockemühl M; Ramadori G
Eur J Gastroenterol Hepatol; 2005 May; 17(5):547-57. PubMed ID: 15827446
[TBL] [Abstract][Full Text] [Related]
36. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
37. Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.
Bauditz J; Wedel S; Lochs H
Gut; 2002 Feb; 50(2):196-200. PubMed ID: 11788559
[TBL] [Abstract][Full Text] [Related]
38. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.
Heuschkel RB; MacDonald TT; Monteleone G; Bajaj-Elliott M; Smith JA; Pender SL
Gut; 2000 Jul; 47(1):57-62. PubMed ID: 10861265
[TBL] [Abstract][Full Text] [Related]
39. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.
Kucharzik T; Lügering N; Weigelt H; Adolf M; Domschke W; Stoll R
Clin Exp Immunol; 1996 Jun; 104(3):483-90. PubMed ID: 9099934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
